Jefferies Financial Group Inc. Cytokinetics Inc Transaction History

Jefferies Financial Group Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$47.86 - $75.05 $1.14 Million - $1.79 Million	-23,800 Reduced 74.33%	8,220 $445,000
Q1 2024 May 13, 2024	BUY	$63.75 - $108.06 $434,265 - $736,104	6,812 Added 27.02%	32,020 $2.24 Million
Q4 2023 Feb 13, 2024	BUY	$26.88 - $83.49 $677,591 - $2.1 Million	25,208 New	25,208 $2.1 Million
Q2 2023 Aug 14, 2023	SELL	$32.62 - $40.75 $145,159 - $181,337	-4,450 Reduced 11.13%	35,550 $1.16 Million
Q1 2023 May 15, 2023	BUY	$33.36 - $45.71 $1.33 Million - $1.83 Million	40,000 New	40,000 $1.41 Million

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.62B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.